Atypical Infantile-onset Pompe Disease with Hypertrophic Cardiomyopathy
- PMID: 28937052
- PMCID: PMC5634097
- DOI: 10.4103/0366-6999.215340
Atypical Infantile-onset Pompe Disease with Hypertrophic Cardiomyopathy
Conflict of interest statement
There are no conflicts of interest.
Figures
References
-
- Bhengu L, Davidson A, du Toit P, Els C, Gerntholtz T, Govendrageloo K, et al. Diagnosis and management of Pompe disease. S Afr Med J. 2014;104:273–4. doi: 10.7196/SAMJ.7386. - PubMed
-
- Tarnopolsky M, Katzberg H, Petrof BJ, Sirrs S, Sarnat HB, Myers K, et al. Pompe disease: Diagnosis and management. Evidence-Based Guidelines from a Canadian Expert Panel. Can J Neurol Sci. 2016;43:472–85. doi: 10.1017/cjn.2016.37. - PubMed
-
- Colan SD, Lipshultz SE, Lowe AM, Sleeper LA, Messere J, Cox GF, et al. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: Findings from the pediatric cardiomyopathy registry. Circulation. 2007;115:773–81. doi: 10.1161/CIRCULATIONAHA.106.621185. - PubMed
-
- Huie ML, Tsujino S, Sklower Brooks S, Engel A, Elias E, Bonthron DT, et al. Glycogen storage disease type II: Identification of four novel missense mutations (D645N, G648S, R672W, R672Q) and two insertions/deletions in the acid alpha-glucosidase locus of patients of differing phenotype. Biochem Biophys Res Commun. 1998;244:921–7. doi: 10.1006/bbrc.1998.8255. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
